Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine (TL01)

This study has been completed.
Sponsor:
Collaborator:
European Union
Information provided by (Responsible Party):
David JM Lewis, St George's, University of London
ClinicalTrials.gov Identifier:
NCT01285141
First received: January 26, 2011
Last updated: December 4, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
No publications provided by St George's, University of London

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):